Selvita S.A. (WSE:SLV)

Market Cap	915.02M
Revenue (ttm)	334.42M
Net Income (ttm)	54.09M
Shares Out	18.36M
EPS (ttm)	2.94
PE Ratio	16.94
Forward PE	49.73
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,435
Average Volume	4,682
Open	47.50
Previous Close	49.35
Day's Range	48.40 - 50.00
52-Week Range	42.65 - 73.00
Beta	0.04
RSI	59.18
Earnings Date	Mar 28, 2025

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, analytical and solid state chemistry, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, auto...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2007
• Employees: 886
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: SLV

Financial Performance

In 2023, Selvita's revenue was 351.85 million, a decrease of -3.48% compared to the previous year's 364.55 million. Earnings were 69.88 million, an increase of 130.55%.